Eli Lilly's close ties to Ireland’s pharma manufacturing sector have just got even stronger, after the US pharma announced plans to double its planned investment in a new
Sandoz has started building for the future after it completes a planned spin-out from parent Novartis, with a major investment in a production plant in Slovenia for its bi
US biotech Moderna has chosen the location of its promised new R&D facility in the UK, selecting the Harwell Science Campus in Oxfordshire to site the unit.
AstraZeneca's revelation in its fourth-quarter results update - that it had decided to build a new $360 million manufacturing facility in Ireland, rather than its home ter
Pollution by the pharmaceutical, healthcare, and agricultural sectors is driving the development of 'superbug' strains of bacteria that have become resistant to every know
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t